NASDAQ: NTRA

Natera, Inc.

Natera, Inc. is a worldwide genetic testing and diagnostics company that is changing how doctors and patients manage genetic disease. The Company develops and commercializes non-invasive methods for analyzing DNA. They operate a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California, and offer a host of proprietary genetic testing services. Since 2009, Natera has launched seven molecular screening tests, many of which are available through major health plans accounting for more than 140 million covered lives in the United States.